COMPOSITIONS FOR TREATMENT OF ANAL GLAND DISEASE
This disclosure relates to a composition comprising an anti-inflammatory agent and an analgesic agent for treating anal gland disease. In particular, the disclosure relates to a composition formulated as a spray or wipe.
1 . A composition comprising hydrocortisone in an amount between about 0.1% to about 10% by weight of the total composition and pramoxine in an amount between about 0.1% to about 15% by weight of the total composition.
2 . The composition of claim 1 , wherein hydrocortisone is in the amount of about 1% by weight of the total composition and pramoxine in is the amount of about 3% by weight of the total composition.
3 . The composition of claim 1 , wherein the pramoxine is pramoxine hydrochloride.
4 . The composition of claim 1 , further comprising diphenhydramine in an amount of about 1% by weight of the total composition.
5 . A composition comprising hydrocortisone in an amount between about 0.1% to about 10% by weight of the total composition and benzocaine in an amount between about 1% to about 15% by weight of the total composition.
6 . The composition of claim 1 further comprising an odor reducing agent.
7 . The composition of claim 6 , wherein the odor reducing agent is in an amount between about 0.1% to about 5% by weight of the total composition.
8 . The composition of claim 7 , wherein the odor reducing agent is in the amount of about 0.5% by weight of the total composition.
9 . The composition of claim 1 further comprising one or more soothing agents.
10 . The composition of claim 9 , wherein the one or more soothing agents is selected from tocopheryl acetate and chamomile extract.
11 . The composition of claim 10 , wherein tocopheryl acetate is in the amount of about 0.01% by weight of the total composition and chamomile extract is in the amount of about 0.1% by weight of the total composition.
12 . The composition of any one of claims 1 - 14 further comprising an oat avenanthramide extract.
13 . The composition of claim 12 , wherein the oat avenanthramide extract is in the amount of about 0.1% to about 5% by weight of the total composition.
14 . The composition of claim 1 further comprising one or more essential oils.
15 . The composition of claim 1 , wherein the composition is formulated as a spray.
16 . The composition of claim 1 , wherein the composition is formulated as a wipe.
17 . The composition of claim 16 , wherein the wipe comprises an absorbent wipe substrate.
18 . A composition comprising hydrocortisone in an amount between about 0.5% to about 10% by weight of the total composition and lidocaine in an amount between about 1% to about 15% by weight of the total composition.
19 . A method of treatment or prevention of anal gland disease, the method comprising administering to a subject in need of such treatment an effective amount of one or more compositions of claim 1 .
20 . The method of claim 19 , wherein the subject is a dog or a cat.